Parameswaran Nair

Featured in: Favicon

wiley.com (+1) Favicon

nejm.org

thelancet.com Favicon

healio.com Favicon

ersjournals.com Favicon

chestnet.org Favicon

plos.org

erj.ersjournals.com Favicon

journals.plos.org

Articles

Mucus plugging may persist in severe asthma despite biologic treatment

May 20, 2024 | healio.com | Richard Gawel |Kristen Dowd |Parameswaran Nair

You've successfully added Asthma and Respiratory Disorders to your alerts. You will receive an email when new content is published. Click Here to Manage Email Alerts We were unable to process your request. Please try again later. If you continue to have this issue please contact [email protected]. Key takeaways: Mucus scores included 6 for the nonbiologic group and 3 for the biologic group.
Response of sputum periostin to anti‐T2 biologics treatment in severe asthma

Apr 23, 2024 | onlinelibrary.wiley.com | Parameswaran Nair |Katherine Radford |Satoshi Nunomura |Manali Mukherjee

DATA AVAILABILITY STATEMENT The data that support the findings of this study are available from the corresponding author upon reasonable request.
In‐vitro Clinical Diagnostics using RNA‐Cleaving DNAzymes

Apr 4, 2024 | chemistry-europe.onlinelibrary.wiley.com | Monsur Ali |Parameswaran Nair |Alfredo Capretta

Over the last three decades, significant advancements have been made in the development of biosensors and bioassays that use RNA-cleaving DNAzymes (RCDs) as molecular recognition elements. While early examples of RCDs were primarily responsive to metal ions, the past decade has seen numerous RCDs reported for more clinically relevant targets such as bacteria, cancer cells, small metabolites, and protein biomarkers.
The effects of pulmonary rehabilitation on inflammatory biomarkers in patients with chronic obstructive pulmonary disease: Protocol for a systematic review and meta-analysis

Jun 27, 2023 | journals.plos.org | Ana Batalha Oliveira |Roger Goldstein |Christopher Farley |Parameswaran Nair

Loading metrics Open AccessStudy Protocol AbstractIntroductionChronic obstructive pulmonary disease (COPD) is a common, preventable lung disease which affects more than 300 million people worldwide. People with COPD have elevated levels of inflammatory biomarkers, which are linked to physiological alterations in the respiratory system and extrapulmonary manifestations.
Prevalence and Preventability of Adverse Medicine Events in a Sample of Australian Aged-Care Residents: A Secondary Analysis of Data from the ReMInDAR Trial (pdf) | Paperity

Apr 26, 2023 | paperity.org | Parameswaran Nair |Kalisch Ellett

Drug Safety, Apr 2023 This is a preview of a remote PDF: https://link.springer.com/content/pdf/10.1007/s40264-023-01299-z.pdf Kalisch Ellett, Lisa M., Dorj, Gerel, Andrade, Andre Q., Bilton, Rebecca L., Rowett, Debra, Whitehouse, Joseph, Lim, Renly, Pratt, Nicole L., Kelly, Thu-Lan, Parameswaran Nair, Nibu, Bereznicki, Luke, Widagdo, Imaina, Roughead, Elizabeth E.. , Drug Safety, 2023, pp. 1-8, DOI: 10.1007/s40264-023-01299-z